{PDOC60031} {PS60031; GARP2} {BEGIN} ************************************************** * Glutamic acid-rich protein 2 (GARP2) signature * ************************************************** The glutamic acid-rich protein 2 (GARP2 is a soluble retinal protein that exists in rod outer segments but is absent in cones. GARP2 is a product of alternative splicing of the beta-subunit of the cGMP-gated ion channel (CNGB1) of rod photoreceptors and contains a unique 8-amino-acid C-terminal extension. It has a high content of proline and glutamate residues. GARP2 has been shown to bind to several retinal proteins including perpherin, and the photoreceptor phosphodiesterase (PDE6) [1,2]. As a signature we used the five last common amino acid and the unique 8-amino- acid C-terminal extension of GARP2. -Consensus pattern: C-D-V-Q-T-R-[VAE]-[MVT]-[GA]-A-G-[GS]-L [The 8 last positions correspond to the unique 8-amino- acid C-terminal extension] -Sequences known to belong to this class detected by the pattern: ALL. -Other sequence(s) detected in Swiss-Prot: NONE. -Expert(s) to contact by email: Cote R.; rick.cote@unh.edu -Last update: March 2015 / First entry. [ 1] Pentia D.C., Hosier S., Cote R.H. "The glutamic acid-rich protein-2 (GARP2) is a high affinity rod photoreceptor phosphodiesterase (PDE6)-binding protein that modulates its catalytic properties." J. Biol. Chem. 281:5500-5505(2006). PubMed=16407240; DOI=10.1074/jbc.M507488200 [ 2] Gibriel A.A.Y., Tate R.J., Yu Y., Rawson-Lax E., Hammer H.M., Tettey J.N.A., Pyne N.J., Converse C.A. "The p.Arg86Gln change in GARP2 (glutamic acid-rich protein-2) is a common West African-related polymorphism." Gene 515:155-158(2013). PubMed=23201897; DOI=10.1016/j.gene.2012.11.005 -------------------------------------------------------------------------------- PROSITE is copyrighted by the SIB Swiss Institute of Bioinformatics and distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND 4.0) License, see https://prosite.expasy.org/prosite_license.html -------------------------------------------------------------------------------- {END}